Teladoc Health — Third Quarter 2026 Earnings Summary

Teladoc Health reported third-quarter 2026 revenue of $605.1 million, a 3% decrease from the prior year, while adjusted EBITDA rose 14% to $79.4 million. The company posted a net loss of $26.9 million for the quarter, or $0.15 per share, compared to a loss of $49.5 million in the same period last year. Revenue growth was driven by the Integrated Care segment, which saw a 2% increase to $398.5 million, whereas the BetterHelp segment experienced a 13% decline to $206.6 million. For the full year 2026, Teladoc expects revenue between $2.395 billion and $2.441 billion and adjusted EBITDA between $277 million and $303 million.